English

Vaneltix Pharma, Inc.

EDGAR

Filing (D) · filed 2017-04-13

66 filing records in this dataset, filed from 1997-11-14 to 2017-04-13. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2007-06-30 · USD

Exact inputs and evidence

Revenue: 571000 USD Source
Revenue: 571000 USD Source

Operating cash flow

-89.6 thousand USD

2007-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -1230344 USD Source
Operating Cash Flow: -1140697 USD Source

Free cash flow

-92.4 thousand USD

2007-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -1230344 USD Source
Operating Cash Flow: -1140697 USD Source
Capital Expenditure: 2725 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 42.7 thousand USD 2010-03-31 Source
Exact value

42652 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

571 thousand USD

2006-07-01 – 2007-06-30

Exact inputs and evidence

Revenue: 80000 USD · 2006-07-01 – 2006-09-30 Source
Revenue: 260000 USD · 2006-10-01 – 2006-12-31 Source
Revenue: 231000 USD · 2007-01-01 – 2007-03-31 Source
Revenue: 571000 USD · 2006-07-01 – 2007-06-30 Source
Revenue: 571000 USD · 2006-07-01 – 2007-03-31 Source

Net income

-3.46 million USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Net income: -2256607 USD · 2008-07-01 – 2009-06-30 Source
Net income: -1688890 USD · 2008-07-01 – 2009-03-31 Source
Net income: 51482 USD · 2009-07-01 – 2009-09-30 Source
Net income: -1007964 USD · 2009-10-01 – 2009-12-31 Source
Net income: -1933639 USD · 2010-01-01 – 2010-03-31 Source

Operating cash flow

-764 thousand USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Operating cash flow: -560765 USD · 2008-07-01 – 2009-06-30 Source
Operating cash flow: -451922 USD · 2008-07-01 – 2009-03-31 Source
Operating cash flow: -250201 USD · 2009-07-01 – 2009-09-30 Source
Operating cash flow: -327904 USD · 2009-07-01 – 2009-12-31 Source
Operating cash flow: -250201 USD · 2009-07-01 – 2009-09-30 Source
Operating cash flow: -655653 USD · 2009-07-01 – 2010-03-31 Source
Operating cash flow: -327904 USD · 2009-07-01 – 2009-12-31 Source

Capital expenditure

270 USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Capital expenditure: 270 USD · 2008-07-01 – 2009-06-30 Source
Capital expenditure: 0 USD · 2008-07-01 – 2009-03-31 Source
Capital expenditure: 0 USD · 2009-07-01 – 2009-09-30 Source
Capital expenditure: 0 USD · 2009-07-01 – 2009-12-31 Source
Capital expenditure: 0 USD · 2009-07-01 – 2009-09-30 Source
Capital expenditure: 0 USD · 2009-07-01 – 2010-03-31 Source
Capital expenditure: 0 USD · 2009-07-01 – 2009-12-31 Source

Free cash flow

-765 thousand USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Operating cash flow: -560765 USD · 2008-07-01 – 2009-06-30 Source
Operating cash flow: -451922 USD · 2008-07-01 – 2009-03-31 Source
Operating cash flow: -250201 USD · 2009-07-01 – 2009-09-30 Source
Operating cash flow: -327904 USD · 2009-07-01 – 2009-12-31 Source
Operating cash flow: -250201 USD · 2009-07-01 – 2009-09-30 Source
Operating cash flow: -655653 USD · 2009-07-01 – 2010-03-31 Source
Operating cash flow: -327904 USD · 2009-07-01 – 2009-12-31 Source
Capital expenditure: 270 USD · 2008-07-01 – 2009-06-30 Source
Capital expenditure: 0 USD · 2008-07-01 – 2009-03-31 Source
Capital expenditure: 0 USD · 2009-07-01 – 2009-09-30 Source
Capital expenditure: 0 USD · 2009-07-01 – 2009-12-31 Source
Capital expenditure: 0 USD · 2009-07-01 – 2009-09-30 Source
Capital expenditure: 0 USD · 2009-07-01 – 2010-03-31 Source
Capital expenditure: 0 USD · 2009-07-01 – 2009-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-04-13.

Financial data available through: 2009-06-30.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2007-06-30
Operating income: 11 of 11 periods available· newest 2009-06-30
Net income: 11 of 11 periods available· newest 2009-06-30
Operating cash flow: 11 of 11 periods available· newest 2009-06-30
Capital expenditure: 11 of 11 periods available· newest 2009-06-30
Total assets: 11 of 11 periods available· newest 2009-06-30
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2009-06-30
Current liabilities: 11 of 11 periods available· newest 2009-06-30
Cash and cash equivalents: 11 of 11 periods available· newest 2009-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 2.59 million

Prior period

−USD 4.84 million

2007-07-01 – 2008-06-30
Current period

−USD 2.26 million

2008-07-01 – 2009-06-30

Exact inputs and evidence

-2256607 − -4844458 = 2587851 USD

-4844458 USD · 2007-07-01 – 2008-06-30
Inspect prior input Prior source
-2256607 USD · 2008-07-01 – 2009-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Vaneltix Pharma, Inc. · 2009-06-30 Vaneltix Pharma, Inc. (edgar:932352) Year-over-year change in Net income: 2587851 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2256607 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#24977 Input fundies:NetIncome: -4844458 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#24977
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.13 million

Prior period

−USD 2.69 million

2007-07-01 – 2008-06-30
Current period

−USD 560,765

2008-07-01 – 2009-06-30

Exact inputs and evidence

-560765 − -2692515 = 2131750 USD

-2692515 USD · 2007-07-01 – 2008-06-30
Inspect prior input Prior source
-560765 USD · 2008-07-01 – 2009-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Vaneltix Pharma, Inc. · 2009-06-30 Vaneltix Pharma, Inc. (edgar:932352) Year-over-year change in Operating cash flow: 2131750 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -560765 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25159 Input fundies:OperatingCashFlow: -2692515 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25159
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-93.7%

Prior period

USD 4,255

2007-07-01 – 2008-06-30
Current period

USD 270

2008-07-01 – 2009-06-30

Exact inputs and evidence

270 − 4255 = -3985 USD

4255 USD · 2007-07-01 – 2008-06-30
Inspect prior input Prior source
270 USD · 2008-07-01 – 2009-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Vaneltix Pharma, Inc. · 2009-06-30 Vaneltix Pharma, Inc. (edgar:932352) Year-over-year change in Capital expenditure: -3985 USD Concept: fundies:CapitalExpenditure Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 270 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25200 Input fundies:CapitalExpenditure: 4255 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25200
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2006-07-01 – 2007-06-30

Revenue USD 571,000 100% of revenue
Operating costs Derived USD 3.8 million 666% of revenue
Operating income −USD 3.23 million −566% of revenue
Tax, interest and other Derived USD 22,392 3.9% of revenue
Net income −USD 3.25 million −570% of revenue

Cash

Operating cash flow −USD 1.23 million −215% of revenue
Capital expenditure USD 2,725 0.5% of revenue
Free cash flow Derived −USD 1.23 million −216% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Operating loss: operating costs were 966% of revenue.
2001 Operating loss: operating costs were 950% of revenue.
2002 Operating loss: operating costs were 999% of revenue.
2003 Operating loss: operating costs were 497% of revenue.
2004 Operating loss: operating costs were 187% of revenue.
2005 Operating loss: operating costs were 618% of revenue.
2006 Operating loss: operating costs were 2,243% of revenue.
2007 Operating loss: operating costs were 666% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 1999-07-01 – 2000-06-30	5589000	54017000 Derived	-48428000	-773000 Derived	-47655000	-23668000 Derived	Source 1999-07-01 – 2000-06-30: 5589000 USD Inspect Revenue Open source 1999-07-01 – 2000-06-30: -48428000 USD Inspect Operating Income Open source 1999-07-01 – 2000-06-30: -47655000 USD Inspect Net Income Open source 1999-07-01 – 2000-06-30: -22773000 USD Inspect Operating Cash Flow Open source 1999-07-01 – 2000-06-30: 895000 USD Inspect Capital Expenditure Open source
2001 2000-07-01 – 2001-06-30	4646000	44141000 Derived	-39495000	-1296000 Derived	-38199000	-28088000 Derived	Source 2000-07-01 – 2001-06-30: 4646000 USD Inspect Revenue Open source 2000-07-01 – 2001-06-30: -39495000 USD Inspect Operating Income Open source 2000-07-01 – 2001-06-30: -38199000 USD Inspect Net Income Open source 2000-07-01 – 2001-06-30: -27777000 USD Inspect Operating Cash Flow Open source 2000-07-01 – 2001-06-30: 311000 USD Inspect Capital Expenditure Open source
2002 2001-07-01 – 2002-06-30	3837000	38317000 Derived	-34480000	-1390000 Derived	-33090000	-28572000 Derived	Source 2001-07-01 – 2002-06-30: 3837000 USD Inspect Revenue Open source 2001-07-01 – 2002-06-30: -34480000 USD Inspect Operating Income Open source 2001-07-01 – 2002-06-30: -33090000 USD Inspect Net Income Open source 2001-07-01 – 2002-06-30: -28436000 USD Inspect Operating Cash Flow Open source 2001-07-01 – 2002-06-30: 136000 USD Inspect Capital Expenditure Open source
2003 2002-07-01 – 2003-06-30	3958000	19656000 Derived	-15698000	-838000 Derived	-14860000	-15641000 Derived	Source 2002-07-01 – 2003-06-30: 3958000 USD Inspect Revenue Open source 2002-07-01 – 2003-06-30: -15698000 USD Inspect Operating Income Open source 2002-07-01 – 2003-06-30: -14860000 USD Inspect Net Income Open source 2002-07-01 – 2003-06-30: -15610000 USD Inspect Operating Cash Flow Open source 2002-07-01 – 2003-06-30: 31000 USD Inspect Capital Expenditure Open source
2004 2003-07-01 – 2004-06-30	7478000	13966000 Derived	-6488000	-4000 Derived	-6484000	-3890000 Derived	Source 2003-07-01 – 2004-06-30: 7478000 USD Inspect Revenue Open source 2003-07-01 – 2004-06-30: -6488000 USD Inspect Operating Income Open source 2003-07-01 – 2004-06-30: -6484000 USD Inspect Net Income Open source 2003-07-01 – 2004-06-30: -3883000 USD Inspect Operating Cash Flow Open source 2003-07-01 – 2004-06-30: 7000 USD Inspect Capital Expenditure Open source
2005 2004-07-01 – 2005-06-30	2177000	13453000 Derived	-11276000	-193000 Derived	-11083000	-12076000 Derived	Source 2004-07-01 – 2005-06-30: 2177000 USD Inspect Revenue Open source 2004-07-01 – 2005-06-30: -11276000 USD Inspect Operating Income Open source 2004-07-01 – 2005-06-30: -11083000 USD Inspect Net Income Open source 2004-07-01 – 2005-06-30: -12068000 USD Inspect Operating Cash Flow Open source 2004-07-01 – 2005-06-30: 8000 USD Inspect Capital Expenditure Open source
2006 2005-07-01 – 2006-06-30	727000	16308000 Derived	-15581000	-244000 Derived	-15337000	-13204000 Derived	Source 2005-07-01 – 2006-06-30: 727000 USD Inspect Revenue Open source 2005-07-01 – 2006-06-30: -15581000 USD Inspect Operating Income Open source 2005-07-01 – 2006-06-30: -15337000 USD Inspect Net Income Open source 2005-07-01 – 2006-06-30: -13171000 USD Inspect Operating Cash Flow Open source 2005-07-01 – 2006-06-30: 33000 USD Inspect Capital Expenditure Open source
2007 2006-07-01 – 2007-06-30	571000	3800644 Derived	-3229644	22392 Derived	-3252036	-1233069 Derived	Source 2006-07-01 – 2007-06-30: 571000 USD Inspect Revenue Open source 2006-07-01 – 2007-06-30: -3229644 USD Inspect Operating Income Open source 2006-07-01 – 2007-06-30: -3252036 USD Inspect Net Income Open source 2006-07-01 – 2007-06-30: -1230344 USD Inspect Operating Cash Flow Open source 2006-07-01 – 2007-06-30: 2725 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 571K 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-06-30	Revenue	4129000	Revenue: 4129000 Open source
20002000-06-30	Revenue	5589000	Revenue: 5589000 Open source
20012001-06-30	Revenue	4646000	Revenue: 4646000 Open source
20022002-06-30	Revenue	3837000	Revenue: 3837000 Open source
20032003-06-30	Revenue	3958000	Revenue: 3958000 Open source
20042004-06-30	Revenue	7478000	Revenue: 7478000 Open source
20052005-06-30	Revenue	2177000	Revenue: 2177000 Open source
20062006-06-30	Revenue	727000	Revenue: 727000 Open source
20072007-06-30	Revenue	571000	Revenue: 571000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-21.5% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-06-30	Year over year	No prior comparable period	Revenue: 4129000 Open source
20002000-06-30	Year over year	35.4%	Revenue: 5589000 Open source Revenue: 4129000 Open source
20012001-06-30	Year over year	-16.9%	Revenue: 4646000 Open source Revenue: 5589000 Open source
20022002-06-30	Year over year	-17.4%	Revenue: 3837000 Open source Revenue: 4646000 Open source
20032003-06-30	Year over year	3.2%	Revenue: 3958000 Open source Revenue: 3837000 Open source
20042004-06-30	Year over year	88.9%	Revenue: 7478000 Open source Revenue: 3958000 Open source
20052005-06-30	Year over year	-70.9%	Revenue: 2177000 Open source Revenue: 7478000 Open source
20062006-06-30	Year over year	-66.6%	Revenue: 727000 Open source Revenue: 2177000 Open source
20072007-06-30	Year over year	-21.5%	Revenue: 571000 Open source Revenue: 727000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -565.6% 2007

Net margin -569.5% 2007

Free cash flow margin -215.9% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19991999-06-30	Operating margin	-1,122%	Operating Income: -46329000 Open source Revenue: 4129000 Open source
20002000-06-30	Operating margin	-866.5%	Operating Income: -48428000 Open source Revenue: 5589000 Open source
20012001-06-30	Operating margin	-850.1%	Operating Income: -39495000 Open source Revenue: 4646000 Open source
20022002-06-30	Operating margin	-898.6%	Operating Income: -34480000 Open source Revenue: 3837000 Open source
20032003-06-30	Operating margin	-396.6%	Operating Income: -15698000 Open source Revenue: 3958000 Open source
20042004-06-30	Operating margin	-86.8%	Operating Income: -6488000 Open source Revenue: 7478000 Open source
20052005-06-30	Operating margin	-518%	Operating Income: -11276000 Open source Revenue: 2177000 Open source
20062006-06-30	Operating margin	-2,143.2%	Operating Income: -15581000 Open source Revenue: 727000 Open source
20072007-06-30	Operating margin	-565.6%	Operating Income: -3229644 Open source Revenue: 571000 Open source
19991999-06-30	Net margin	-1,082.1%	Net Income: -44680000 Open source Revenue: 4129000 Open source
20002000-06-30	Net margin	-852.7%	Net Income: -47655000 Open source Revenue: 5589000 Open source
20012001-06-30	Net margin	-822.2%	Net Income: -38199000 Open source Revenue: 4646000 Open source
20022002-06-30	Net margin	-862.4%	Net Income: -33090000 Open source Revenue: 3837000 Open source
20032003-06-30	Net margin	-375.4%	Net Income: -14860000 Open source Revenue: 3958000 Open source
20042004-06-30	Net margin	-86.7%	Net Income: -6484000 Open source Revenue: 7478000 Open source
20052005-06-30	Net margin	-509.1%	Net Income: -11083000 Open source Revenue: 2177000 Open source
20062006-06-30	Net margin	-2,109.6%	Net Income: -15337000 Open source Revenue: 727000 Open source
20072007-06-30	Net margin	-569.5%	Net Income: -3252036 Open source Revenue: 571000 Open source
19991999-06-30	Free cash flow margin	Not reported	Revenue: 4129000 Open source
20002000-06-30	Free cash flow margin	-423.5%	Revenue: 5589000 Open source Operating Cash Flow: -22773000 Open source Capital Expenditure: 895000 Open source
20012001-06-30	Free cash flow margin	-604.6%	Revenue: 4646000 Open source Operating Cash Flow: -27777000 Open source Capital Expenditure: 311000 Open source
20022002-06-30	Free cash flow margin	-744.6%	Revenue: 3837000 Open source Operating Cash Flow: -28436000 Open source Capital Expenditure: 136000 Open source
20032003-06-30	Free cash flow margin	-395.2%	Revenue: 3958000 Open source Operating Cash Flow: -15610000 Open source Capital Expenditure: 31000 Open source
20042004-06-30	Free cash flow margin	-52%	Revenue: 7478000 Open source Operating Cash Flow: -3883000 Open source Capital Expenditure: 7000 Open source
20052005-06-30	Free cash flow margin	-554.7%	Revenue: 2177000 Open source Operating Cash Flow: -12068000 Open source Capital Expenditure: 8000 Open source
20062006-06-30	Free cash flow margin	-1,816.2%	Revenue: 727000 Open source Operating Cash Flow: -13171000 Open source Capital Expenditure: 33000 Open source
20072007-06-30	Free cash flow margin	-215.9%	Revenue: 571000 Open source Operating Cash Flow: -1230344 Open source Capital Expenditure: 2725 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.2M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-06-30	Operating cash flow	Not reported	No source recorded
20002000-06-30	Operating cash flow	-22773000	Operating Cash Flow: -22773000 Open source
20012001-06-30	Operating cash flow	-27777000	Operating Cash Flow: -27777000 Open source
20022002-06-30	Operating cash flow	-28436000	Operating Cash Flow: -28436000 Open source
20032003-06-30	Operating cash flow	-15610000	Operating Cash Flow: -15610000 Open source
20042004-06-30	Operating cash flow	-3883000	Operating Cash Flow: -3883000 Open source
20052005-06-30	Operating cash flow	-12068000	Operating Cash Flow: -12068000 Open source
20062006-06-30	Operating cash flow	-13171000	Operating Cash Flow: -13171000 Open source
20072007-06-30	Operating cash flow	-1230344	Operating Cash Flow: -1230344 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.2M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-06-30	Free cash flow	Unavailable	No source recorded
20002000-06-30	Free cash flow	-23668000	Operating Cash Flow: -22773000 Open source Capital Expenditure: 895000 Open source
20012001-06-30	Free cash flow	-28088000	Operating Cash Flow: -27777000 Open source Capital Expenditure: 311000 Open source
20022002-06-30	Free cash flow	-28572000	Operating Cash Flow: -28436000 Open source Capital Expenditure: 136000 Open source
20032003-06-30	Free cash flow	-15641000	Operating Cash Flow: -15610000 Open source Capital Expenditure: 31000 Open source
20042004-06-30	Free cash flow	-3890000	Operating Cash Flow: -3883000 Open source Capital Expenditure: 7000 Open source
20052005-06-30	Free cash flow	-12076000	Operating Cash Flow: -12068000 Open source Capital Expenditure: 8000 Open source
20062006-06-30	Free cash flow	-13204000	Operating Cash Flow: -13171000 Open source Capital Expenditure: 33000 Open source
20072007-06-30	Free cash flow	-1233069	Operating Cash Flow: -1230344 Open source Capital Expenditure: 2725 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1999-06-30	Liabilities / assets	Not reported	Total Assets: 64427000 Open source
2000-06-30	Liabilities / assets	Not reported	Total Assets: 60308000 Open source
2001-06-30	Liabilities / assets	Not reported	Total Assets: 50249000 Open source
2002-06-30	Liabilities / assets	Not reported	Total Assets: 24044000 Open source
2003-06-30	Liabilities / assets	Not reported	Total Assets: 6078000 Open source
2004-06-30	Liabilities / assets	Not reported	Total Assets: 21891000 Open source
2005-06-30	Liabilities / assets	Not reported	Total Assets: 14152000 Open source
2006-06-30	Liabilities / assets	Not reported	Total Assets: 5258000 Open source
2007-06-30	Liabilities / assets	Not reported	Total Assets: 387871 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.08× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19991999-06-30	Current assets / current liabilities	2.19×	Current Assets: 28499000 Open source Current Liabilities: 13038000 Open source
20002000-06-30	Current assets / current liabilities	2.67×	Current Assets: 35198000 Open source Current Liabilities: 13207000 Open source
20012001-06-30	Current assets / current liabilities	3.15×	Current Assets: 36895000 Open source Current Liabilities: 11704000 Open source
20022002-06-30	Current assets / current liabilities	3.39×	Current Assets: 20054000 Open source Current Liabilities: 5917000 Open source
20032003-06-30	Current assets / current liabilities	1.18×	Current Assets: 4119000 Open source Current Liabilities: 3489000 Open source
20042004-06-30	Current assets / current liabilities	5.23×	Current Assets: 20906000 Open source Current Liabilities: 4001000 Open source
20052005-06-30	Current assets / current liabilities	5.11×	Current Assets: 13207000 Open source Current Liabilities: 2583000 Open source
20062006-06-30	Current assets / current liabilities	1.95×	Current Assets: 4715000 Open source Current Liabilities: 2415000 Open source
20072007-06-30	Current assets / current liabilities	0.08×	Current Assets: 122812 Open source Current Liabilities: 1604626 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 1999-07-01 – 2000-06-30	−USD 47.66 million Exact value Exact value: -47655000 USD 1999-07-01 – 2000-06-30: -47655000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2000-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -47655000 USD Concept: fundies:NetIncome Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:NetIncome: -47655000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0000912057-02-037274.txt#7019 The citation records this snapshot. The page link may show a newer release later.	−USD 22.77 million Exact value Exact value: -22773000 USD 1999-07-01 – 2000-06-30: -22773000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2000-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -22773000 USD Concept: fundies:OperatingCashFlow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22773000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0000912057-02-037274.txt#7273 The citation records this snapshot. The page link may show a newer release later.	USD 895,000 Exact value Exact value: 895000 USD 1999-07-01 – 2000-06-30: 895000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2000-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 895000 USD Concept: fundies:CapitalExpenditure Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 895000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0000912057-02-037274.txt#7327 The citation records this snapshot. The page link may show a newer release later.	−USD 23.67 million Calculation and evidence -22773000 − 895000 USD Exact free cash flow: -23668000 USD 1999-07-01 – 2000-06-30: -22773000 USD · Inspect Operating Cash Flow · Source 1999-07-01 – 2000-06-30: 895000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2000-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -23668000 USD Concept: free-cash-flow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22773000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0000912057-02-037274.txt#7273 Input fundies:CapitalExpenditure: 895000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0000912057-02-037274.txt#7327 The citation records this snapshot. The page link may show a newer release later.
2001 2000-07-01 – 2001-06-30	−USD 38.2 million Exact value Exact value: -38199000 USD 2000-07-01 – 2001-06-30: -38199000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2001-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -38199000 USD Concept: fundies:NetIncome Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:NetIncome: -38199000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-03-031997.txt#6964 The citation records this snapshot. The page link may show a newer release later.	−USD 27.78 million Exact value Exact value: -27777000 USD 2000-07-01 – 2001-06-30: -27777000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2001-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -27777000 USD Concept: fundies:OperatingCashFlow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27777000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-03-031997.txt#7203 The citation records this snapshot. The page link may show a newer release later.	USD 311,000 Exact value Exact value: 311000 USD 2000-07-01 – 2001-06-30: 311000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2001-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 311000 USD Concept: fundies:CapitalExpenditure Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 311000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-03-031997.txt#7243 The citation records this snapshot. The page link may show a newer release later.	−USD 28.09 million Calculation and evidence -27777000 − 311000 USD Exact free cash flow: -28088000 USD 2000-07-01 – 2001-06-30: -27777000 USD · Inspect Operating Cash Flow · Source 2000-07-01 – 2001-06-30: 311000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2001-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -28088000 USD Concept: free-cash-flow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27777000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-03-031997.txt#7203 Input fundies:CapitalExpenditure: 311000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-03-031997.txt#7243 The citation records this snapshot. The page link may show a newer release later.
2002 2001-07-01 – 2002-06-30	−USD 33.09 million Exact value Exact value: -33090000 USD 2001-07-01 – 2002-06-30: -33090000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2002-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -33090000 USD Concept: fundies:NetIncome Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:NetIncome: -33090000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-04-034356.txt#6838 The citation records this snapshot. The page link may show a newer release later.	−USD 28.44 million Exact value Exact value: -28436000 USD 2001-07-01 – 2002-06-30: -28436000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2002-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -28436000 USD Concept: fundies:OperatingCashFlow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28436000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-04-034356.txt#7091 The citation records this snapshot. The page link may show a newer release later.	USD 136,000 Exact value Exact value: 136000 USD 2001-07-01 – 2002-06-30: 136000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2002-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 136000 USD Concept: fundies:CapitalExpenditure Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 136000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-04-034356.txt#7136 The citation records this snapshot. The page link may show a newer release later.	−USD 28.57 million Calculation and evidence -28436000 − 136000 USD Exact free cash flow: -28572000 USD 2001-07-01 – 2002-06-30: -28436000 USD · Inspect Operating Cash Flow · Source 2001-07-01 – 2002-06-30: 136000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2002-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -28572000 USD Concept: free-cash-flow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -28436000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-04-034356.txt#7091 Input fundies:CapitalExpenditure: 136000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001047469-04-034356.txt#7136 The citation records this snapshot. The page link may show a newer release later.
2003 2002-07-01 – 2003-06-30	−USD 14.86 million Exact value Exact value: -14860000 USD 2002-07-01 – 2003-06-30: -14860000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2003-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -14860000 USD Concept: fundies:NetIncome Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:NetIncome: -14860000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-05-045741.txt#12742 The citation records this snapshot. The page link may show a newer release later.	−USD 15.61 million Exact value Exact value: -15610000 USD 2002-07-01 – 2003-06-30: -15610000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2003-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -15610000 USD Concept: fundies:OperatingCashFlow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15610000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-05-045741.txt#13098 The citation records this snapshot. The page link may show a newer release later.	USD 31,000 Exact value Exact value: 31000 USD 2002-07-01 – 2003-06-30: 31000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2003-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 31000 USD Concept: fundies:CapitalExpenditure Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 31000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-05-045741.txt#13151 The citation records this snapshot. The page link may show a newer release later.	−USD 15.64 million Calculation and evidence -15610000 − 31000 USD Exact free cash flow: -15641000 USD 2002-07-01 – 2003-06-30: -15610000 USD · Inspect Operating Cash Flow · Source 2002-07-01 – 2003-06-30: 31000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2003-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -15641000 USD Concept: free-cash-flow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15610000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-05-045741.txt#13098 Input fundies:CapitalExpenditure: 31000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-05-045741.txt#13151 The citation records this snapshot. The page link may show a newer release later.
2004 2003-07-01 – 2004-06-30	−USD 6.48 million Exact value Exact value: -6484000 USD 2003-07-01 – 2004-06-30: -6484000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2004-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -6484000 USD Concept: fundies:NetIncome Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:NetIncome: -6484000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-06-063816.txt#16781 The citation records this snapshot. The page link may show a newer release later.	−USD 3.88 million Exact value Exact value: -3883000 USD 2003-07-01 – 2004-06-30: -3883000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2004-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -3883000 USD Concept: fundies:OperatingCashFlow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3883000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-06-063816.txt#17183 The citation records this snapshot. The page link may show a newer release later.	USD 7,000 Exact value Exact value: 7000 USD 2003-07-01 – 2004-06-30: 7000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2004-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 7000 USD Concept: fundies:CapitalExpenditure Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-06-063816.txt#17236 The citation records this snapshot. The page link may show a newer release later.	−USD 3.89 million Calculation and evidence -3883000 − 7000 USD Exact free cash flow: -3890000 USD 2003-07-01 – 2004-06-30: -3883000 USD · Inspect Operating Cash Flow · Source 2003-07-01 – 2004-06-30: 7000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2004-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -3890000 USD Concept: free-cash-flow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3883000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-06-063816.txt#17183 Input fundies:CapitalExpenditure: 7000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001104659-06-063816.txt#17236 The citation records this snapshot. The page link may show a newer release later.
2005 2004-07-01 – 2005-06-30	−USD 11.08 million Exact value Exact value: -11083000 USD 2004-07-01 – 2005-06-30: -11083000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2005-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -11083000 USD Concept: fundies:NetIncome Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:NetIncome: -11083000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15490 The citation records this snapshot. The page link may show a newer release later.	−USD 12.07 million Exact value Exact value: -12068000 USD 2004-07-01 – 2005-06-30: -12068000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2005-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -12068000 USD Concept: fundies:OperatingCashFlow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12068000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15792 The citation records this snapshot. The page link may show a newer release later.	USD 8,000 Exact value Exact value: 8000 USD 2004-07-01 – 2005-06-30: 8000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2005-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 8000 USD Concept: fundies:CapitalExpenditure Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15828 The citation records this snapshot. The page link may show a newer release later.	−USD 12.08 million Calculation and evidence -12068000 − 8000 USD Exact free cash flow: -12076000 USD 2004-07-01 – 2005-06-30: -12068000 USD · Inspect Operating Cash Flow · Source 2004-07-01 – 2005-06-30: 8000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2005-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -12076000 USD Concept: free-cash-flow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12068000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15792 Input fundies:CapitalExpenditure: 8000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15828 The citation records this snapshot. The page link may show a newer release later.
2006 2005-07-01 – 2006-06-30	−USD 15.34 million Exact value Exact value: -15337000 USD 2005-07-01 – 2006-06-30: -15337000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2006-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -15337000 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:NetIncome: -15337000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15490 The citation records this snapshot. The page link may show a newer release later.	−USD 13.17 million Exact value Exact value: -13171000 USD 2005-07-01 – 2006-06-30: -13171000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2006-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -13171000 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13171000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15792 The citation records this snapshot. The page link may show a newer release later.	USD 33,000 Exact value Exact value: 33000 USD 2005-07-01 – 2006-06-30: 33000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2006-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 33000 USD Concept: fundies:CapitalExpenditure Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15828 The citation records this snapshot. The page link may show a newer release later.	−USD 13.2 million Calculation and evidence -13171000 − 33000 USD Exact free cash flow: -13204000 USD 2005-07-01 – 2006-06-30: -13171000 USD · Inspect Operating Cash Flow · Source 2005-07-01 – 2006-06-30: 33000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2006-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -13204000 USD Concept: free-cash-flow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13171000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15792 Input fundies:CapitalExpenditure: 33000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-000486.txt#15828 The citation records this snapshot. The page link may show a newer release later.
2007 2006-07-01 – 2007-06-30	−USD 3.25 million Exact value Exact value: -3252036 USD 2006-07-01 – 2007-06-30: -3252036 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2007-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -3252036 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:NetIncome: -3252036 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-002191.txt#29659 The citation records this snapshot. The page link may show a newer release later.	−USD 1.23 million Exact value Exact value: -1230344 USD 2006-07-01 – 2007-06-30: -1230344 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2007-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -1230344 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1230344 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-002191.txt#29894 The citation records this snapshot. The page link may show a newer release later.	USD 2,725 Exact value Exact value: 2725 USD 2006-07-01 – 2007-06-30: 2725 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2007-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 2725 USD Concept: fundies:CapitalExpenditure Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2725 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-002191.txt#29946 The citation records this snapshot. The page link may show a newer release later.	−USD 1.23 million Calculation and evidence -1230344 − 2725 USD Exact free cash flow: -1233069 USD 2006-07-01 – 2007-06-30: -1230344 USD · Inspect Operating Cash Flow · Source 2006-07-01 – 2007-06-30: 2725 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2007-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -1233069 USD Concept: free-cash-flow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1230344 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-002191.txt#29894 Input fundies:CapitalExpenditure: 2725 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-08-002191.txt#29946 The citation records this snapshot. The page link may show a newer release later.
2008 2007-07-01 – 2008-06-30	−USD 4.84 million Exact value Exact value: -4844458 USD 2007-07-01 – 2008-06-30: -4844458 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2008-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -4844458 USD Concept: fundies:NetIncome Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:NetIncome: -4844458 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#24977 The citation records this snapshot. The page link may show a newer release later.	−USD 2.69 million Exact value Exact value: -2692515 USD 2007-07-01 – 2008-06-30: -2692515 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2008-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -2692515 USD Concept: fundies:OperatingCashFlow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2692515 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25159 The citation records this snapshot. The page link may show a newer release later.	USD 4,255 Exact value Exact value: 4255 USD 2007-07-01 – 2008-06-30: 4255 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2008-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 4255 USD Concept: fundies:CapitalExpenditure Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4255 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25200 The citation records this snapshot. The page link may show a newer release later.	−USD 2.7 million Calculation and evidence -2692515 − 4255 USD Exact free cash flow: -2696770 USD 2007-07-01 – 2008-06-30: -2692515 USD · Inspect Operating Cash Flow · Source 2007-07-01 – 2008-06-30: 4255 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2008-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -2696770 USD Concept: free-cash-flow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2692515 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25159 Input fundies:CapitalExpenditure: 4255 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25200 The citation records this snapshot. The page link may show a newer release later.
2009 2008-07-01 – 2009-06-30	−USD 2.26 million Exact value Exact value: -2256607 USD 2008-07-01 – 2009-06-30: -2256607 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaneltix Pharma, Inc. · 2009-06-30 Vaneltix Pharma, Inc. (edgar:932352) Net Income: -2256607 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ANetIncome&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:NetIncome: -2256607 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#24977 The citation records this snapshot. The page link may show a newer release later.	−USD 560,765 Exact value Exact value: -560765 USD 2008-07-01 – 2009-06-30: -560765 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaneltix Pharma, Inc. · 2009-06-30 Vaneltix Pharma, Inc. (edgar:932352) Operating Cash Flow: -560765 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3AOperatingCashFlow&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -560765 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25159 The citation records this snapshot. The page link may show a newer release later.	USD 270 Exact value Exact value: 270 USD 2008-07-01 – 2009-06-30: 270 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaneltix Pharma, Inc. · 2009-06-30 Vaneltix Pharma, Inc. (edgar:932352) Capital Expenditure: 270 USD Concept: fundies:CapitalExpenditure Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352/explain?concept=fundies%3ACapitalExpenditure&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 270 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25200 The citation records this snapshot. The page link may show a newer release later.	−USD 561,035 Calculation and evidence -560765 − 270 USD Exact free cash flow: -561035 USD 2008-07-01 – 2009-06-30: -560765 USD · Inspect Operating Cash Flow · Source 2008-07-01 – 2009-06-30: 270 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaneltix Pharma, Inc. · 2009-06-30 Vaneltix Pharma, Inc. (edgar:932352) Free cash flow: -561035 USD Concept: free-cash-flow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T15:04:10Z Snapshot: c86f9f2821ef12f908aa19ae7e5a5050d3eb8768d2ca8c4395beb9f42ff1088e Dimensions: Consolidated View: https://fundies.io/companies/edgar/932352?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -560765 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25159 Input fundies:CapitalExpenditure: 270 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/932352/0001013762-09-001726.txt#25200 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

66 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000932352, 932352, edgar:932352

Also known as MEGABIOS CORP, Urigen Pharmaceuticals, Inc., VALENTIS INC

Vaneltix Pharma, Inc.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2006-07-01 – 2007-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation